Evidence map›Paper›PMID 36766793›Full record

ArticleCells2023

Ultrastructural Analysis of Cancer Cells Treated with the Radiopharmaceutical Radium Dichloride ([

Joel Félix Silva Diniz Filho, Aline Oliveira da Silva de Barros, Martha Sahylí Ortega Pijeira, Eduardo Ricci-Junior, Victor Midlej, Mariana Pelissari Monteiro Aguiar Baroni, Clenilton Costa Dos Santos, Luciana Magalhães Rebelo Alencar, Ralph Santos-Oliveira

Abstract read
In one paragraph

Article in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Joel Félix Silva Diniz FilhoBiophysics and Nanosystems Laboratory, Department of Physics, Federal University of Maranhão, São Luis 65065690, MA, Brazil.
Aline Oliveira da Silva de BarrosLaboratory of Nanoradiopharmacy and Synthesis of New Radiopharmaceuticals, Brazilian Nuclear Energy Commission, Nuclear Engineering Institute, Rio de Janeiro 21941906, RJ, Brazil.
Martha Sahylí Ortega PijeiraLaboratory of Nanoradiopharmacy and Synthesis of New Radiopharmaceuticals, Brazilian Nuclear Energy Commission, Nuclear Engineering Institute, Rio de Janeiro 21941906, RJ, Brazil.ORCID 0000-0001-9307-4954
Eduardo Ricci-JuniorSchool of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro 21941900, RJ, Brazil.ORCID 0000-0002-2550-696X
Victor MidlejLaboratory of Structural Biology, Oswaldo Cruz Institute (FIOCRUZ), Rio de Janeiro 21040900, RJ, Brazil.ORCID 0000-0001-9294-6597
Mariana Pelissari Monteiro Aguiar BaroniDepartment of Natural Science and Mathematics, Federal Institute of Education, Science and Technology (IFSP), Campus São Paulo, São Paulo 01109010, SP, Brazil.ORCID 0000-0002-4670-122X
Clenilton Costa Dos SantosBiophysics and Nanosystems Laboratory, Department of Physics, Federal University of Maranhão, São Luis 65065690, MA, Brazil.
Luciana Magalhães Rebelo AlencarBiophysics and Nanosystems Laboratory, Department of Physics, Federal University of Maranhão, São Luis 65065690, MA, Brazil.ORCID 0000-0001-8210-2016
Ralph Santos-OliveiraLaboratory of Nanoradiopharmacy and Synthesis of New Radiopharmaceuticals, Brazilian Nuclear Energy Commission, Nuclear Engineering Institute, Rio de Janeiro 21941906, RJ, Brazil.ORCID 0000-0002-0905-481X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of alpha-particle (α-particle) radionuclides, especially [

Indexed as

NeoplasmsRadiumAlpha ParticlesCell MembraneHumansRadioisotopesRadiopharmaceuticalsRadioisotopesRadiopharmaceuticalsRadiumcell deathcell mechanismradiopharmaceuticaltargeted alpha therapy

Identifiers

PMID36766793
PMCPMC9913731

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.